**Major Corporate Developments**
CHINA RAILWAY (00390) recently secured 11 major engineering projects with a combined contract value of approximately 50.215 billion yuan.
CHINA CRSC (03969): Won four significant railway market projects from July to August.
CTF SERVICES (00659) plans to issue 2.218 billion Hong Kong dollars in convertible bonds, convertible into approximately 10% of Sincere Watch (00697) shares.
Shanghai Pharma (02607): Shanghai Shiye Yangtze River Delta is transferring 40% equity in Shanghai Pharma Group to Shanghai Shiye for approximately 6.7215 billion yuan.
Tianjin Port Development (03382) subsidiary plans to acquire 5% stake in Eurasia International Company for 95.403 million yuan.
Tianjin Port Development (03382) plans to acquire 40% stake in Alliance International Company for 723 million yuan, increasing total holdings to 100%.
Sincere Watch Holdings (00697): Beijing Robotics Fund invests in Quanzhi Bo, continuing to strengthen robotics industry investment layout.
Borealis (01333) entered into strategic cooperation agreement with Mingyang Mining to promote electrification and intelligent development of mining transportation.
China Biologic Products Holdings (01177): LM-350 "CDH17 ADC" completed first patient enrollment in Phase I clinical trial in Australia.
Xinjiang Xinxin Mining (03833): Proposes to issue A-shares.
Jihong Holdings (02603) expects net profit attributable to shareholders to increase 55%-65% year-over-year in the first three quarters.
**Share Buybacks and Holdings Changes**
TENCENT (00700) spent 550 million Hong Kong dollars on September 25 to repurchase 844,000 shares.
Midea Group (00300) spent 200 million yuan on September 25 to repurchase 2.7455 million A-shares.
Anta Sports (02020) spent 99.819 million Hong Kong dollars on September 25 to repurchase 1.065 million shares.
Haidilao (02517) plans to use up to 100 million Hong Kong dollars for further H-share buybacks.
GIANT BIOGENE (02367) received an additional 1.15 million shares from controlling shareholder Juzi Holding.
Goldwind Technology (02208) shareholder Hexie Health has cumulatively reduced holdings by approximately 57.14185 million shares.